Needed: a clearer explanation of why diversity in clinical trials is important

Clinical trials in the U.S. have long skewed toward recruiting mostly white people. That justifies closely examining what this means for non-white people — and rethinking what we mean by diversity, writes @ArthurCaplan.

Read the full article here

Related Articles